Filgrastim Completed Phase 2 Trials for severe or persistent diarrhea / Gastrointestinal Complications / Unspecified Childhood Solid Tumor, Protocol Specific Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00258180Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy